Definitive Contract 75A50125C00006
Award Date 9/30/25
Potential Completion Date 3/31/27
Potential Value $744K
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
France
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $98,593,151.00 definitive, cost sharing contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to Osivax, a foreign-owned for-profit organization based in Paris, France. The contract is for the clinical proof of concept of OVX836, a single-shot broadly protective influenza A vaccine that aims to provide immediate protection against emerging pandemic strains. The contract has an ultimate completion date of July 24, 2028 and was...
- This federal contract award was issued by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services (HHS). The purpose of this Firm Fixed Price Delivery Order is to procure an Influenza A(H2Nx) virus vaccine candidate(s) and conduct the associated clinical trial. The total ceiling value of this contract is $21,404,609.80, with a completion date of January 31, 2027. The prime contractor is Seqirus Inc.,...
- US Biologic, Inc. was awarded a $664,774 firm fixed-price definitive contract by the Office of the Assistant Secretary for Preparedness and Response on July 19, 2021, to conduct research and development for a rapid-response oral influenza vaccine under the Beyond the Needle (BTN) initiative. The contract, which was not set aside for small businesses or other designated groups, required performance in Memphis, Tennessee, with an ultimate completion date of February 29, 2024. This R&D effort...
- This is a firm fixed price delivery order contract awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer of goods. The contract has a potential value of $339,189.20 and is under a larger Indefinite Delivery Vehicle (IDV) contract named "Pandemic Influenza Preparedness and Response 2016-2021" with a potential value up to $5.87 billion. This contract...
- This is a firm fixed price delivery order awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Sanofi Pasteur Inc., a foreign-owned for-profit manufacturer of vaccines and pharmaceuticals. The $587,398.00 award is for funding Sanofi Pasteur's development of current Good Manufacturing Practice (cGMP) influenza vaccine master and working seed lots under the Pandemic Influenza Preparedness and Response 2012-2016 indefinite...
- This is a $2,025,000.00 Firm Fixed Price Delivery Order contract awarded to Sanofi Pasteur Inc. by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response. The contract is part of the Pandemic Influenza Preparedness and Response 2016-2021 Indefinite Delivery Vehicle (IDV), which has a potential value of $5.87 billion. Sanofi Pasteur Inc. is a foreign-owned, for-profit manufacturer of vaccines, pharmaceuticals, and medical supplies. The contract...
- This $642,000.00 firm-fixed-price delivery order was awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Seqirus USA Inc. through its Seqirus Usa, Inc. division. The order was placed under the Pandemic Influenza Preparedness and Response 2012-2016 Indefinite Delivery Contract, a multi-year vehicle managed by ASPR. The contract supports the delivery of influenza vaccines, which Seqirus specializes in manufacturing and supplying to various...
- This is a $18,005,775.00 cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Vaxine PTY LTD, a for-profit organization based in Australia. The contract is for the advanced development of the H7-Advax pandemic vaccine candidate through Phase 1 clinical trials, including the delivery of preliminary data regarding the adjuvant formulations and the manufactured product. The contract does not have a set-aside designation,...
- The U.S. federal government has awarded a $141,185 delivery order contract to Seqirus USA Inc., a global biotechnology company specializing in influenza vaccine development, manufacturing, and delivery. The contract, with a performance period ending on August 30, 2024, is for the supply of influenza virus vaccines. Seqirus USA Inc. is the prime contractor and will be delivering the vaccines under this firm-fixed-price contract. This award is not associated with a set-aside program. Seqirus USA...
- The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a firm fixed price delivery order contract to Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer of goods. The contract, valued at $1,673,698.13, is for the provision of vaccine products and services to support the Pandemic Influenza Preparedness and Response program, a 5-year Indefinite Delivery Vehicle (IDV) potentially valued at $5.87 billion. This award does not have...